Most adenocarcinomas in the lower female genital tract (cervix, vagina, vulva) arise in the
cervix and are associated with high-risk human papillomavirus (HPV) infection. However …

The new WHO classification of tumors of the female genitalia entails some changes,
especially those of prognostic and therapeutic relevance: there is a return to the term …

Most cervical carcinomas and their related lesions are attributed to an infection by human
papillomavirus (HPV). The infection usually starts in the basal cells at the squamocolumnar …

Cervical adenocarcinoma is a heterogenous group of tumours with various aetiologies,
molecular drivers, morphologies, response to treatment and prognosis. It has become …

Human papillomavirus (HPV) is an oncogenic virus associated with the development of
several human cancers. Primary vaginal, vulvar, and anal adenocarcinomas are rare and, to …

Premalignant lesions of the lower female genital tract encompassing the cervix, vagina and
vulva are variably common and many, but by no means all, are related to infection by human …

Modern classification schemes divide cervical adenocarcinomas into human papillomavirus
(HPV)-associated and HPV-independent types. The precursor lesions of the former are well …

Uterine cervical carcinoma secondarily involving the genitourinary tract is rarely
documented histologically. These tumors present a unique diagnostic challenge as they can …

Adenocarcinomas exhibiting gastric differentiation represent a recently described and
uncommon subtype of non–human papillomavirus (HPV)-related cervical adenocarcinoma …

So-called gastric-type adenocarcinoma and related premalignant lesions have been
characterized in the cervix, but similar lesions are not widely recognized in the vagina. We …